BreastGPT
AI platform for breast cancer patient engagement
Platform · Cloud SaaSCompany source
Company profile
About Elaitra Ltd
Elaitra Ltd is a medical imaging AI company focused on improving breast cancer detection through Digital Breast Tomosynthesis (DBT) imaging. The company addresses the critical challenge that late breast cancer detection costs approximately 30,000 lives annually in the USA alone. Elaitra's AI platform comprises two key products: BreastGPT, which engages patients in the screening process, and ViewFinder, which assists radiologists in reading DBT images more efficiently. The technology aims to solve detection's worst pain-points by making the reading process faster and more accurate. According to user feedback, 92% of practitioners would use Elaitra in their practice, with radiologists noting that the platform helps them find lesions more accurately and efficiently. The company targets the breast cancer screening market, which is particularly significant given that breast cancer is the world's most prevalent cancer. Elaitra's solution is designed to accelerate the diagnostic workflow while improving detection accuracy, addressing both efficiency and clinical outcome challenges in radiology practices.
Company description Elaitra Ltd official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Elaitra Ltd?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- breast cancer
Who it serves
- breast imaging centers
- healthcare providers
- radiology practices
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsUK · USA
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
ViewFinder
AI-assisted image reading for Digital Breast Tomosynthesis
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Dynamic AI-assisted ipsilateral tissue matching for digital breast tomosynthesis.European journal of radiology · Nov 1, 2025
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
ViewFinder Software Version 1.1K223501 · 510k · Apr 21, 2023
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
92% practitioner adoption rate
Percentage of practitioners who would use Elaitra in their practice
Improved lesion detection accuracy
More accurate and efficient in finding lesions according to user testimonials
Accelerated reading time
Quickens the DBT image reading process
Unnamed radiologists (survey respondents)
Accelerated reading and improved accuracy in Digital Breast Tomosynthesis imaging
92% would use Elaitra in their practice
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Stephen Morrell
Contact Person
06 · Company updates
Updates from Elaitra Ltd
Recent articles published on Elaitra Ltd's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.